tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (SHPMF)
OTHER OTC:SHPMF
US Market
SHPMF
Shanghai Pharmaceuticals Holding Co
RESEARCH TOOLSreports
Want to see SHPMF full AI Analyst Report?

Shanghai Pharmaceuticals Holding Co (SHPMF) Financial Statements

12 Followers

Shanghai Pharmaceuticals Holding Co Financial Overview

Shanghai Pharmaceuticals Holding Co's market cap is currently $8.28B. The company's EPS TTM is $0.05556968; its P/E ratio is 6.62; and it has a dividend yield of 3.35%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 283.58B¥ 275.25B¥ 260.30B¥ 231.98B¥ 215.82B
Gross Profit¥ 30.42B¥ 30.63B¥ 30.93B¥ 30.49B¥ 28.54B
Operating Income¥ 9.94B¥ 8.14B¥ 7.67B¥ 9.01B¥ 8.21B
EBITDA¥ 14.37B¥ 12.06B¥ 10.90B¥ 12.44B¥ 10.55B
Net Income¥ 5.72B¥ 4.55B¥ 3.77B¥ 5.62B¥ 5.09B
Balance Sheet
Cash & Short-Term Investments¥ 43.08B¥ 44.38B¥ 40.67B¥ 37.01B¥ 22.39B
Total Assets¥ 233.15B¥ 221.21B¥ 211.97B¥ 198.13B¥ 163.44B
Total Debt¥ 49.48B¥ 47.79B¥ 42.90B¥ 38.56B¥ 31.69B
Net Debt¥ 16.76B¥ 12.05B¥ 12.38B¥ 11.16B¥ 9.30B
Total Liabilities¥ 143.36B¥ 137.47B¥ 131.65B¥ 120.13B¥ 104.37B
Stockholders' Equity¥ 75.89B¥ 71.68B¥ 68.52B¥ 67.06B¥ 49.36B
Cash Flow
Free Cash Flow¥ 3.83B¥ 3.43B¥ 2.26B¥ 2.06B¥ 942.55M
Operating Cash Flow¥ 6.15B¥ 5.83B¥ 5.23B¥ 4.74B¥ 5.06B
Investing Cash Flow¥ -3.98B¥ 415.98M¥ -2.49B¥ -12.47B¥ -6.02B
Financing Cash Flow¥ -5.65B¥ -1.86B¥ 231.85M¥ 12.14B¥ 1.57B
Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Income Statement >

Shanghai Pharmaceuticals Holding Co Debt to Assets

Balance Sheet >

Shanghai Pharmaceuticals Holding Co Cash Flow

Cash Flow >

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

Earnings >